These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26236982)

  • 1. Incorrect Role of Funder/Sponsor Statement.
    JAMA Intern Med; 2015 Aug; 175(8):1426. PubMed ID: 26236982
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisions to Role of Funder/Sponsor Statement.
    JAMA; 2024 Sep; ():. PubMed ID: 39259565
    [No Abstract]   [Full Text] [Related]  

  • 3. Addition of Open Access, Funding/Support, and Role of Funder/Sponsor Information.
    JAMA Pediatr; 2017 Oct; 171(10):1019. PubMed ID: 28806443
    [No Abstract]   [Full Text] [Related]  

  • 4. Missing Funding/Support, Role of the Funder/Sponsor, and Additional Contributions Statements.
    JAMA; 2017 Dec; 318(21):2142. PubMed ID: 31381638
    [No Abstract]   [Full Text] [Related]  

  • 5. Error in Role of the Funder/Sponsor.
    JAMA Netw Open; 2022 Jun; 5(6):e2219924. PubMed ID: 35704325
    [No Abstract]   [Full Text] [Related]  

  • 6. Error in the Role of the Funder/Sponsor Section.
    JAMA Netw Open; 2023 May; 6(5):e2318204. PubMed ID: 37227731
    [No Abstract]   [Full Text] [Related]  

  • 7. Additions to Funding/Support and Role of the Funder/Sponsor Sections.
    JAMA; 2023 Sep; 330(10):974. PubMed ID: 37698580
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorrect Funder.
    JAMA; 2017 May; 317(18):1912. PubMed ID: 28492883
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorrect Disclosure and Role of Funder Statements.
    JAMA Netw Open; 2024 Jun; 7(6):e2423203. PubMed ID: 38857054
    [No Abstract]   [Full Text] [Related]  

  • 10. Clarification of Role of Funder Statement.
    JAMA Netw Open; 2021 Jan; 4(1):e2035088. PubMed ID: 33410873
    [No Abstract]   [Full Text] [Related]  

  • 11. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
    Georgias C; Grunow A; Olderog M; May A; Paulus U
    Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived credibility of a "neutral" abortion-related message and its sponsor.
    Spadafora M; Pasadeos Y
    J Psychol; 1986 Mar; 120(2):137-41. PubMed ID: 3735148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the peer review pathologist in good laboratory practices studies: a sponsor perspective.
    Hailey JR
    Toxicol Pathol; 2014 Jan; 42(1):278-82. PubMed ID: 24178581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sponsor/contract laboratory communication: a team approach to quality.
    Caulfield M; Franklin W; Muncie JA; Nelson J; Ross T; Russo AS; Schulte MC; Sottolano LA; Vincifora CJ; Pappacena BM
    Qual Assur; 1993; 2(1-2):191-6. PubMed ID: 8156212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic partnership: the successful contract laboratory-sponsor relationship.
    Scozzie JA
    Qual Assur; 1995 Jun; 4(2):101-8. PubMed ID: 8720152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A COMMON, BUT INCORRECT, STATEMENT CONCERNING THE NUMBER OF BACTERIA IN MILK.
    Breed RS
    Science; 1916 Nov; 44(1143):749-50. PubMed ID: 17742312
    [No Abstract]   [Full Text] [Related]  

  • 18. Funder/provider options for health in New Zealand--some new thoughts.
    Bolitho D; Johnston J
    N Z Health Hospital; 1990; 42(5):3-5. PubMed ID: 10108925
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA outlook of events reporting after ticagrelor or clopidogrel in the PLATO Trial: impact of sponsor censoring dates, drug discontinuation, and withdrawal of consent.
    Serebruany VL
    Cardiology; 2011; 120(3):169-71. PubMed ID: 22418766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unintended consequences of disclosure: effect of manipulating sponsor identification on the perceived credibility and effectiveness of smoking cessation advertisements.
    Byrne S; Guillory JE; Mathios AD; Avery RJ; Hart PS
    J Health Commun; 2012; 17(10):1119-37. PubMed ID: 23057726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.